| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -38.32M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, KYTX returned +118.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -10.4% |
| 1 year | +118.7% |
| All-time high | $27.17 (Feb 2024) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in KYTX would be worth today ›No. Kyverna Therapeutics, Inc. has not paid a dividend in the past 12 months.
Kyverna Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol KYTX.
Kyverna Therapeutics, Inc. is part of the Healthcare sector.
Kyverna Therapeutics, Inc. has a market cap of 520.72M USD, based on the latest quote.
Kyverna Therapeutics, Inc. is expected to report earnings around Nov 11, 2026. That date is an estimate and has not been confirmed by the company.
